Developing a potentially immunologically inert tetracycline-regulatable viral vector for gene therapy in the peripheral nerve
- 3 April 2014
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 21 (6) , 549-557
Abstract
Viral vector-mediated gene transfer of neurotrophic factors is an emerging and promising strategy to promote the regeneration of injured peripheral nerves. Unfortunately, the chronic exposure to neurotrophic factors results in local trapping of regenerating axons or other unwanted side effects. Therefore, tight control of therapeutic gene expression is required. The tetracycline/ doxycycline-inducible system is considered to be one of the most promising systems for regulating heterologous gene expression. However, an immune response directed against the transactivator protein rtTA hampers further translational studies. Immunogenic proteins fused with the Gly-Ala repeat of the Epstein-Barr virus Nuclear Antigen-1 protein have been shown to successfully evade the immune system. In this article, we used this strategy to demonstrate that a chimeric transactivator, created by fusing the Gly-Ala repeat with rtTA and embedded in a lentiviral vector (i) retained its transactivator function in vitro, in muscle explants, and in vivo following injection into the rat peripheral nerve, (ii) exhibited a reduced leaky expression, and (iii) had an immune-evasive advantage over rtTA as shown in a novel bioassay for human antigen presentation. The current findings are an important step toward creating a clinically applicable potentially immune-evasive tetracycline-regulatable viral vector system. © 2014 Macmillan Publishers LimitedKeywords
This publication has 43 references indexed in Scilit:
- Nerve surgery and gene therapy: a neurobiological and clinical perspectiveJournal of Hand Surgery (European Volume), 2011
- Gene Therapy for the Peripheral Nervous System: A Strategy to Repair the Injured Nerve?Current Gene Therapy, 2011
- Differential effects of lentiviral vector‐mediated overexpression of nerve growth factor and glial cell line‐derived neurotrophic factor on regenerating sensory and motor axons in the transected peripheral nerveEuropean Journal of Neuroscience, 2008
- Neuroregenerative effects of lentiviral vector-mediated GDNF expression in reimplanted ventral rootsMolecular and Cellular Neuroscience, 2008
- Rescue and sprouting of motoneurons following ventral root avulsion and reimplantation combined with intraspinal adeno-associated viral vector-mediated expression of glial cell line-derived neurotrophic factor or brain-derived neurotrophic factorExperimental Neurology, 2004
- A humanized system for pharmacologic control of gene expressionNature Medicine, 1996
- Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor.Proceedings of the National Academy of Sciences, 1995
- Transcriptional Activation by Tetracyclines in Mammalian CellsScience, 1995
- GDNF: a Potent Survival Factor for Motoneurons Present in Peripheral Nerve and MuscleScience, 1994
- Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.Proceedings of the National Academy of Sciences, 1992